Turn Therapeutics Inc.
TTRX· Nasdaq
When Turn Therapeutics Inc. reports, what it reported each quarter, and how the stock took the results.
9 quarters. Sep 30, 2024 to Sep 30, 2026. mixed units.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 9, 2026 · pre-market | Nov 9, 2026 | 40 d | 10-Q | |||||
Turn Therapeutics Inc. · CIK 2023016 · Engraved from SEC EDGAR
| — |
| — |
| -$0.21 |
| +4.9% |
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 12, 2026 | 43 d | 10-Q | — | — | -$0.20 | 6.0% |
|---|
| Q1 2026 | Mar 31, 2026 | May 11, 2026 · after-hours | May 11, 2026 | 41 d | 10-Q | — | — | -$0.03 | +7.8% |
|---|
| FY 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 31, 2026 · after-hours | Mar 31, 2026 | 90 d | 10-K | — | — | — | 3.0% | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · pre-market | Nov 13, 2025 | 44 d | 10-Q | — | — | -$0.07 | 6.9% | |
| Q2 2025 | Jun 30, 2025 | — | — | — | — | — | — | -$0.05 | — | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | — | — | -$0.01 | — | |
| FY 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | — | — | — | — | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | — | — | — | — | — | -$0.03 | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The stock’s move from the last close before each release to the first close after it, over the last 5 releases. Largest: +7.8% after Q1 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.